Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nasdaq
Biotech
MapLight goes public via $250M IPO to fund Cobenfy competitor
MapLight is heading to the Nasdaq this morning via a $250 million IPO the biotech will use to advance its challenger to BMS’ Cobenfy.
James Waldron
Oct 27, 2025 6:45am
Singapore drug discovery platform heads to Nasdaq via SPAC deal
Oct 2, 2025 9:50am
Barinthus enters reverse merger with metabolic disease biotech
Sep 30, 2025 10:39am
LB Pharmaceuticals eyes $228M in IPO cash
Sep 8, 2025 3:16pm
Heartflow pumps up IPO plans to $300M
Aug 6, 2025 11:20am
Coronary AI diagnostic developer Heartflow files $100M IPO
Jul 18, 2025 11:43am
